Evaluation of an E-Learning Program for Community Pharmacists for Dispensing Emicizumab (Hemlibra) in France: Nationwide Cross-Sectional Study

Overview

Journal JMIR Form Res

Publisher JMIR Publications

Specialty Biomedical Engineering

Date 2024 Apr 4

PMID 38574351

Authors

Valerie Chamouard

Julie Freyssenge

Beatrice Clairaz-Mahiou

Felicia Ferrera Bibas

Laurie Fraticelli

Affiliations

Soon will be listed here.

Abstract

Background: Since June 2021, patients with hemophilia A with antifactor VIII inhibitors and those with severe hemophilia A without antifactor VIII inhibitors treated with Hemlibra have had to choose between a community or hospital pharmacy. The French reference center for hemophilia developed the HEMOPHAR e-learning program for community pharmacists for dispensing emicizumab.

Objective: This study aims to evaluate the efficiency and safety of this new care pathway by assessing the HEMOPHAR e-learning program.

Methods: The methodology is based on Kirkpatrick's model for evaluating the immediate reaction of trained community pharmacists (level 1), their level of acquired knowledge (level 2), and their professional practice after 3 months of dispensation (level 3).

Results: The HEMOPHAR e-learning program reached a large audience, with 67% (337/502) of the eligible community pharmacists following it. The immediate reaction was overall satisfying. High rates of engagement were reported with 63.5% (214/337) to 73.3% (247/337) of completed training modules, along with high rates of success with quizzes of 61.5% (174/337) to 95.7% (244/337). We observed that 83.9% (193/230) of the community pharmacists needed less than 2 attempts to pass the quiz of the module related to professional practice, while the other quizzes required more attempts. Advice on compliance and drug interactions were most frequently provided to patients by the community pharmacists.

Conclusions: This study suggests ways to improve the training of community pharmacists and to optimize coordination with treatment centers. This study also reports on the feasibility of switching to a community pharmacy in a secure pharmaceutical circuit, including in the context of a rare bleeding disease.

Trial Registration: ClinicalTrials.gov NCT05449197; https://clinicaltrials.gov/study/NCT05449197.

International Registered Report Identifier (irrid): RR2-10.2196/43091.

Citing Articles

Comparative evaluation of access to emicizumab (Hemlibra®) for people with haemophilia A in community and hospital pharmacies in France.

Cabon M, Chamouard V, Freyssenge J, Fraticelli L Eur J Public Health. 2024; 34(5):866-871.

PMID: 39209530 PMC: 11430965. DOI: 10.1093/eurpub/ckae131.

References

Evans A, Evans S, Roberts D . The use of public health e-learning resources by pharmacists in Wales: a quantitative evaluation. Int J Pharm Pract. 2016; 24(4):294-7. DOI: 10.1111/ijpp.12248. View

Fraticelli L, Freyssenge J, Prome-Combel E, Agnellet E, Dargaud Y, Chamouard V . Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model. JMIR Res Protoc. 2023; 12:e43091. PMC: 10034610. DOI: 10.2196/43091. View

Seston E, Schafheutle E, Willis S, Karolczak-Bayatti M, Lane J, White S . Preparing pharmacists for the Community Pharmacist Consultation Service: a questionnaire survey. Int J Pharm Pract. 2022; 31(1):32-37. DOI: 10.1093/ijpp/riac076. View

Pherson E, Shermock K, Efird L, Gilmore V, Nesbit T, LeBlanc Y . Development and implementation of a postdischarge home-based medication management service. Am J Health Syst Pharm. 2014; 71(18):1576-83. DOI: 10.2146/ajhp130764. View

Patton A, Liu Y, Hartwig D, May J, Moon J, Stoner S . Community pharmacy transition of care services and rural hospital readmissions: A case study. J Am Pharm Assoc (2003). 2017; 57(3S):S252-S258.e3. DOI: 10.1016/j.japh.2017.02.019. View

Melody K, McCartney E, Sen S, Duenas G . Optimizing care transitions: the role of the community pharmacist. Integr Pharm Res Pract. 2018; 5:43-51. PMC: 5741037. DOI: 10.2147/IPRP.S87947. View

Mahlangu J, Oldenburg J, Paz-Priel I, Negrier C, Niggli M, Mancuso M . Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors. N Engl J Med. 2018; 379(9):811-822. DOI: 10.1056/NEJMoa1803550. View

Yeung C, Santesso N, Pai M, Kessler C, Key N, Makris M . Care models in the management of haemophilia: a systematic review. Haemophilia. 2016; 22 Suppl 3:31-40. PMC: 5283751. DOI: 10.1111/hae.13000. View

Saffouh El Hajj M, Al-Ziftawi N, Stewart D, Al-Khater D . Community pharmacists' participation in adult vaccination: A cross-sectional survey based on the theoretical domains framework. Br J Clin Pharmacol. 2022; 89(2):773-786. PMC: 9538350. DOI: 10.1111/bcp.15529. View

10.

Chamouard V, Fraticelli L, Freyssenge J, Claustre C, Negrier C, El Khoury C . PHAREO study: Perceived and observed accessibility to therapeutic drugs used for treating patients with inherited bleeding disorders. J Clin Pharm Ther. 2022; 47(10):1667-1675. DOI: 10.1111/jcpt.13718. View

11.

Ciliberti R, Bragazzi N, Bonsignore A . The Implementation of the Professional Role of the Community Pharmacist in the Immunization Practices in Italy to Counteract Vaccine Hesitancy. Pharmacy (Basel). 2020; 8(3). PMC: 7558843. DOI: 10.3390/pharmacy8030155. View

12.

Beny K, du Sartz de Vigneulles B, Carrouel F, Bourgeois D, Gay V, Negrier C . Haemophilia in France: Modelisation of the Clinical Pathway for Patients. Int J Environ Res Public Health. 2022; 19(2). PMC: 8775796. DOI: 10.3390/ijerph19020646. View

13.

Van Gaalen A, Brouwer J, Schonrock-Adema J, Bouwkamp-Timmer T, Jaarsma A, Georgiadis J . Gamification of health professions education: a systematic review. Adv Health Sci Educ Theory Pract. 2020; 26(2):683-711. PMC: 8041684. DOI: 10.1007/s10459-020-10000-3. View

14.

Brewster S, Holt R, Portlock J, Price H . The role of community pharmacists and their position in the delivery of diabetes care: an update for medical professionals. Postgrad Med J. 2020; 96(1138):473-479. DOI: 10.1136/postgradmedj-2020-137511. View

15.

Helling T, Martin L, Martin M, Mitchell M . Failure events in transition of care for surgical patients. J Am Coll Surg. 2014; 218(4):723-31. DOI: 10.1016/j.jamcollsurg.2013.12.026. View

16.

Grundgeiger T, Kolb L, Korb M, Mengelkamp C, Held V . Training students to use syringe pumps: an experimental comparison of e-learning and classroom training. Biomed Tech (Berl). 2015; 61(2):211-20. DOI: 10.1515/bmt-2014-0116. View

17.

Willis S, Seston E, Family H, White S, Cutts C . Extending the scope of community pharmacists' practice to patients requiring urgent care - An evaluation of a training programme using the Theoretical Domains Framework. Health Soc Care Community. 2019; 27(4):999-1010. DOI: 10.1111/hsc.12717. View

18.

Hake K, Carroll J, Somma McGivney M, Coley K . Pharmacist peer coaching in a traditional community chain pharmacy: Implementation and perceptions. J Am Pharm Assoc (2003). 2021; 61(4S):S85-S90. DOI: 10.1016/j.japh.2021.02.010. View

19.

Oka G, Roussel-Robert V, Levivien C, Lopez I, Pieragostini R . Assessment of the clinical perception, quality of life and satisfaction of patients with severe congenital haemophilia A without inhibitor after 1 year of emicizumab therapy. Haemophilia. 2023; 29(3):709-715. DOI: 10.1111/hae.14755. View

20.

Kizaki H, Ota T, Mashima S, Nakamura Y, Kiyokawa S, Kominato H . Questionnaire survey investigation of the present status of dietetic consultation at community pharmacies from the perspectives of registered dietitians and pharmacists. BMC Health Serv Res. 2021; 21(1):935. PMC: 8425041. DOI: 10.1186/s12913-021-06959-3. View